Site #5 — Quincy, Massachusetts

Site #5 is a clinical research site located in Quincy, Massachusetts, United States 02169.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Site #5 has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Netherton Syndrome.

Sponsors: Quoin Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Quincy

Browse all research sites in Massachusetts · View every site in Quincy

• Beacon Clinical Research
• Dana Farber Community Cancer Care-Quincy
• Research Site
• Care Access - Quincy
• South Suburban Oncology Center
• Commonwealth Hematology Oncology PC-Quincy
• Commonwealth Hematology-Oncology P.C. - Quincy
• Alzheimer's Disease Center
• Alzheimers Disease Center
• Alzheimer Disease Center
• Valeant Site 04
• Care Access

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site #5?

Site #5 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site #5 conducted?

Site #5 has 2 clinical trials on record, with 2 currently active. Their work covers Netherton Syndrome.

Is Site #5 accredited by Crixeo Clinical Trials?

Site #5 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site #5?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.